NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/25/2023
Back to search
Official data from USPTO
RENNANO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
RENNANO
ST13
US500000079313763Class
5, 31, 42
Filing
79313763
Registration
6714941
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
03/25/2023
Trademark type
Word
Nice classes
5, 31, 42
Filing date
02/24/2021
Registration date
05/03/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/03/2022
Last transaction
05/03/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
CN
Examiner
THOMPSON, HEATHER
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Representatives
Michelle E. Tochtrop Pearne & Gordon LLP
Technical classification
Nice Classes
Class 5Class 31Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Vaccines; pharmaceutical preparations for the treatment of immune system related diseases and disorders; medicines for the treatment of cancer; diagnostic preparations for medical purposes; biochemical medicines for the treatment of tumorsinfectious diseasesinflammation and autoimmune diseases; medicines for human purposes for the treatment of tumorsinfectious diseasesinflammation and autoimmune diseases; drugs for medical purposes for the treatment of tumorsinfectious diseasesinflammation and autoimmune diseases; biological preparations for medical purposes for the treatment of tumorsinfectious diseasesinflammation and autoimmune diseases; active pharmaceutical ingredients being chemical and biological preparations for pharmaceutical purposesantibodies for the treatment of human and animal diseases; diagnostic preparations for medical and veterinary purposes; dietetic preparations adapted for medical use; medicines for veterinary purposes for the treatment of tumorsinfectious diseasesinflammation and autoimmune diseases
Class 31
Live trees; live plants; live animals; poultrylive; pigslive; hamsterslive; live laboratory animals; plant seeds; fodder; litter for animals
Class 42
Conducting early evaluation in the field of new pharmaceutical products; development of products for others; consulting services in the field of technology development in the fields of pharmaceutical research and development; research and development of new products; pharmaceutical research services; quality control inspection in the field of pharmaceutical research and development; biochemical research and analysis; research and development services in the field of antibodies; medical and scientific researchconducting clinical trials for others; biological research; development of pharmaceutical preparations and medicines; product testing; pharmaceutical products development services; evaluation of pharmaceuticals; technological researchpharmaceutical research
Publications
History of USPTO decisions and trademark events.
25 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/10/2022
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
09/04/2022
XXCR
GENERIC MADRID TRANSACTION CREATED
09/04/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/03/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
05/03/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/15/2022
PUBO
PUBLISHED FOR OPPOSITION
02/15/2022
GPNX
NOTIFICATION PROCESSED BY IB
02/14/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/26/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/26/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/26/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/08/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/07/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/07/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/07/2022
RFNT
REFUSAL PROCESSED BY IB
11/05/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/08/2021
RFRR
REFUSAL PROCESSED BY MPU
10/08/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/24/2021
CNRT
NON-FINAL ACTION WRITTEN
09/23/2021
DOCK
ASSIGNED TO EXAMINER
09/19/2021
MAFR
APPLICATION FILING RECEIPT MAILED
07/01/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/27/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/24/2021
Continuous trademark protection
Get notified about every new filing that threatens RENNANO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.